Industry Watch Alert Home The Centers for Medicare & Medicaid Services announced it is extending the application deadline for prescription drug manufacturers to participate in
The Trump Administration announced expanded fraud prevention actions across Medicare and Medicaid, signaling a shift toward real-time oversight, increased transparency, and heightened program integrity expectations for payer organizations.
CMS proposes 2027 Exchange regulations focused on lowering premiums, expanding plan flexibility, and strengthening subsidy oversight and program integrity for payers.
The Consolidated Appropriations Act, 2026 extends Medicare telehealth and hospital-at-home programs while delaying Medicaid DSH cuts, reinforcing long-term oversight and utilization management considerations for healthcare payers.
An executive analysis of the White House Great Healthcare Plan proposal, what it could mean for payers and providers, current congressional status, and realistic timelines for potential healthcare policy changes.
A new White House initiative coordinates federal agencies, funding, and data-driven goals to expand addiction treatment and recovery, with key signals for healthcare payers.
The recent ARPA-H announcement outlining the ADVOCATE initiative signals a medium-to-high strategic impact for payers over the next 3–7 years.
ChatGPT Health is a new, dedicated space within ChatGPT that lets consumers securely connect medical records and wellness apps to receive personalized, physician-informed health guidance while maintaining enhanced privacy protections.
The Centers for Medicare & Medicaid Services announced a $50 billion Rural Health Transformation Program, awarding funding to all 50 states beginning in 2026. This signals a meaningful shift in how care may be delivered, reviewed, and evaluated in rural markets.
